WO2004084922A1 - 魚介類用感染防御剤 - Google Patents
魚介類用感染防御剤 Download PDFInfo
- Publication number
- WO2004084922A1 WO2004084922A1 PCT/JP2004/003884 JP2004003884W WO2004084922A1 WO 2004084922 A1 WO2004084922 A1 WO 2004084922A1 JP 2004003884 W JP2004003884 W JP 2004003884W WO 2004084922 A1 WO2004084922 A1 WO 2004084922A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- fish
- shellfish
- infection
- protective agent
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/80—Feeding-stuffs specially adapted for particular animals for aquatic animals, e.g. fish, crustaceans or molluscs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
Definitions
- the present invention relates to a fish and shellfish infection control agent, a fish and shellfish feed, and a method for improving the survival rate of fish and shellfish.
- biologics include Bacillus subtilis, Brepibacterium lactofarmentum, Corynebacterium dallucum, Escherichia coli, Lactobacillus acidophilus, Streptococcus sacrifophilus, Streptomyces supper Prevention and treatment of viral and bacterial diseases of fish and crustaceans containing bactericidal products of bacteria such as nachensis or bifidobacterium thermophilum has been reported.
- Patent Documents 1 and 2 Patent Documents 1 and 2.
- Patent Document 3 feeds for fish and shellfish characterized by the combination of Enterococcus fezium (Patent Literature 4) and fish feeds containing pan yeast containing more selenium than ordinary yeast have been reported (Patent Literature). 5) o
- Patent Documents 1 and 2 are not always satisfactory in antibacterial activity, storage stability, and stability in water. Furthermore, the biological preparations using live bacteria described in Patent Documents 3 to 5 have a problem that strict control is required for the production process and storage of the preparation.
- Patent Document 1 Japanese Patent Application Laid-Open No. 6-181656
- Patent Document 4 Patent No. 2727517
- Patent Document 5 Patent No. 3013871 Disclosure of the Invention
- An object of the present invention is to provide an anti-infection agent for fish and shellfish as a biological preparation, which exhibits remarkable antibacterial activity, and has excellent storage stability and stability in water.
- the present inventors have conducted intensive studies in order to solve the above-mentioned problems, and as a result, a biologic containing a killed bacterial cell of Lactobacillus pi ant arum or a processed product thereof has been described at a glance. I found it to be solved.
- Lactobacillus plantarum (Lactobacillus pi ant arum) killed bacterial cells or a processed product thereof, comprising a seafood infection protective agent
- Lactobacillus plantarum (Lactobacillus pi ant arum) is a Lactobacillus plantarum L-137 strain (Lactobacillus pi an tar urn L-137, accession number FERM BP-08607).
- Lactobacillus pi ant arum (Lactobacillus pi ant arum)
- the content of bacterial cells or processed products is 0.01 to 95% by mass based on the total amount.
- a feed for fish and shellfish comprising the agent for preventing infection of fish and shellfish according to any one of (1) to (9) above, and
- Lactobacillus plantarum L-137 Representative examples of the bacteria belonging to Lactobacillus plantarum used in the present invention include Lactobacillus plantarum L-137, Lactobacillus plantarum JCM1149 reference strain, and Lactobacillus planarum L-. Lactobacillus plantarum L-137 is most preferred.
- the above Lactobacillus plan Yuramu L-137 is a patented biological depository center of the National Institute of Advanced Industrial Science and Technology. First, it has been deposited under accession number FE RM BP-08607 (transferred from FE RM P-155317 deposited on January 30, 1995).
- the bacterium used in the present invention can be obtained by culturing it in a medium such as a natural medium, a synthetic medium, or a semi-synthetic medium.
- a medium a medium containing a nitrogen source and a carbon source is used.
- Nitrogen sources include, for example, meat extract, peptone, dartene, casein, yeast extract, amino acids, etc.
- carbon sources include, for example, glucose, xylose, fructoses, wild boar, malus, Water syrup, koji juice, starch, bacas, bran, molasses, glycerin and the like are used.
- inorganic substances for example, ammonium sulfate, potassium phosphate, magnesium chloride, salt, iron, manganese, molybdenum, etc., and various vitamins and the like can be added.
- the culturing temperature is about 25 to 40 ° C, preferably about 27 to 35 ° C
- the culturing time is about 12 to 48 hours, and aeration and shaking may be performed.
- the pH of the medium is about 3-6, preferably about 4-6.
- Dead cells can be obtained by inactivating the collected viable cells or the culture solution containing viable cells, for example, by heating, ultraviolet irradiation, formalin treatment, or the like.
- the heating temperature is usually about 60 to 100 ° C, preferably about 70 to 90 ° C.
- the heating means may be a known means using heating and heating.
- the heating time is usually about 5 to 40 minutes, preferably about 10 to 30 minutes after reaching the desired temperature.
- a processed product of dead cells can be obtained, for example, by freeze-drying or spray-drying dead cells. Also, by adding appropriate excipients such as dextrin cellulose to the dead cells, This can also be obtained by freeze-drying or spray-drying.
- the processed product of dead cells may also be an extract of dead cells.
- the fish and shellfish in the present invention are not particularly limited, and may be any of freshwater fish, saltwater fish, and crustaceans, and may be any of cultured fish and ornamental fish.
- freshwater fish include penguin, koi, rainbow trout, ayu, tilapia, crucian carp, goldfish (for example, lanchiyu, Japanese gold, comet, vermilion, Dutch Shishigashira, spot gold, etc.), guppy, apistogramma, daiscus, etc.
- saltwater fish include bluefin tuna, puri, Thailand, coho salmon, black mackerel, flounder, flounder, black soy, trough, amberjack, and the like.
- salmon and trout are included in both freshwater fish and seawater fish.
- crustaceans include prawns, black tigers, ⁇ shevids, korejaebi and crabs.
- the main cause of fish and shellfish diseases is infectious diseases caused by pathogenic bacteria, viruses, parasites and the like, and the seafood infection protective agent of the present invention can be applied to any of these infectious diseases.
- Bacteria in bacterial infection include Escherichia coli, Salmonella, Pasteurella, Vibrio, Streptococcus, and filamentous fungi.
- viruses in virus infection include baculovirus, rhabdovirus, and virus that kills epipis (PRDV: Penaeid Rod-Shaped DNA Virus).
- worms skin parasites commonly known as worms (for example, Benedeni a ser iol ae, Benedenia, Benedenia hoshinai, Benedenia epinephel i ), Neobenedenia 'SP (Neobenedeni a sp.), Etc. ⁇ , fish gill parasites commonly known as ramushi (eg, Heteraxine heterocerca Zeuxapia j aponic a, Vibagina Thailand (Bivagina tai), etc. ⁇ , coccidium, etc.
- ramushi eg, Heteraxine heterocerca Zeuxapia j aponic a, Vibagina Thailand (Bivagina tai), etc. ⁇ , coccidium, etc.
- the coccidium includes parasites such as myxosporidium, microsporidium, which is a cause of so-called coccidiomycosis in Tiger swine.
- the infection-controlling agent for fish and shellfish of the present invention is Lactobacillus plantarum.
- the mixing ratio of the killed cells or the processed product thereof to the whole preparation is preferably about 0.01 to 95% by mass, and more preferably about 0.1 to 50% by mass.
- Dosage forms include pellets, tablets, liquids, powders, granules, pastes and the like. Such preparations can be brought into contact with fish and shellfish or given orally.
- Solid excipients or diluents include, for example, fish meal, bone meal, skim milk, cottonseed meal, flour, wheat germ, rice bran, brewer's yeast, cellulose, vitamins (eg, one carotene, vitamin D 3 , menadione Sodium bisulfite, sodium tocopherol, thiamine mononitrate, riboflavin, pyridoxine monohydrochloride, cyanocobalamin, piotin, wild boar] ⁇ nicotine, nicotinic acid, calcium pantothenate, folic acid, choline chloride, paraaminobenzoic acid, vitamin C Or minerals (eg, magnesium sulfate, disodium phosphate, potassium disodium phosphate, iron citrate, calcium lactate, aluminum hydroxide, zinc sulfate, copper sulfate, manganese sulfate, calcium iodate, cobalt sulfate) Etc.) It is below.
- liquid excipient or diluent examples include water and a mixture of water and alcohol.
- the anti-infection agent for fish and shellfish of the present invention can be easily produced by mixing the killed cells of Lactobacillus planta or its treated product with the above-mentioned excipients or diluents. At the time of mixing, the mixture may be heated, if desired, to obtain a flake-form preparation. The preparation of the present invention thus produced may be used as a feed for fish and shellfish.
- the concentration of dead cells or a processed product thereof in the feed is preferably more than about 0 ppm and not more than 200 ppm, more preferably about 0.1 to 200 ppm, Most preferably, it is 0.1 to 50 ppm.
- the melanism of the formulation of the present invention in protection of fish and shellfish infection is due to the enhancement of complement activity and the increase in neutrophil count. It is thought to be due to addition.
- the anti-infection agent for fish and shellfish of the present invention When the anti-infection agent for fish and shellfish of the present invention is administered to seafood, it is possible to effectively prevent or treat fish and shellfish infectious diseases, an increase in body weight of fish and shellfish is observed, and the growth and survival rate of fish and shellfish are improved. I do.
- the infection-controlling agent for fish and shellfish of the present invention is preferably 0.0005 to 5 mg per day per 1 kg of body weight of fish and shellfish, in terms of dead cells of the lactic acid bacterium or a processed product thereof. It is more preferred to give ⁇ 0.5 mg, most preferably from 0.005 to 0.125 mg.
- Lactobacillus planarum L-137 (Accession No. FERM BP-08607) was inoculated into 6 L of medium containing 001%, salt 0.001%, and sucrose fatty acid ester 0.055%, and incubated at 32 ° C for 24 hours. Cultured for hours. After the culture, the culture was centrifuged at 5000 rpm for 35 minutes to collect the cells.
- the obtained cells were well dispersed in physiological saline and centrifuged at 5000 rpm for 35 minutes, and the supernatant was removed to collect the cells. After repeating this operation three times, the cells were dispersed in ion-exchanged water, heated at 70 ° C. for 10 minutes, and lyophilized to obtain about 7 g of heat-killed cells. (Production of pellets from dead cells)
- Brown fish meal 65.6 parts by mass, a-starch 3.4 parts by mass, dextrin 3.4 parts by mass, soy lecithin 4.2 parts by mass, menadione sodium bisulfite 0.014228 parts by mass, thiamine mononitrate 0.
- Neutrophils were collected from the bladder according to Endou et al.'S method (Fisheries science 64 (4), 644-645 (1997)). To the obtained neutrophil suspension (Hanks buffer) After addition of Pan Blue staining solution to stain dead cells, the number of viable cells was counted using a hemocytometer. The results are shown in Table 2.
- red sea bream on the test diet showed a marked increase in neutrophils compared to red bream before and on the control diet. This indicates that the intake of the test feed increased the immune function and increased the ability to protect against infection.
- peripheral blood was collected from the tail into a Spitz tube and stored in a cool place for 24 hours.
- the clot was peeled off along the wall of the Spitz tube with a glass rod, and then centrifuged (3000 rpm, 15 rpm). And 4) were used to prepare serum.
- the bactericidal activity of serum is determined by the method of Yamamoto and Iida (Fish pathol ogy, 30 (2) 123-124 (1995)). Table 3 summarizes the results.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Polymers & Plastics (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Mycology (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Food Science & Technology (AREA)
- Zoology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Birds (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Insects & Arthropods (AREA)
- Marine Sciences & Fisheries (AREA)
- Biotechnology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
Description
Claims
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2005504045A JPWO2004084922A1 (ja) | 2003-03-26 | 2004-03-22 | 魚介類用感染防御剤 |
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003-086370 | 2003-03-26 | ||
| JP2003086370 | 2003-03-26 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| WO2004084922A1 true WO2004084922A1 (ja) | 2004-10-07 |
Family
ID=33095059
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/JP2004/003884 Ceased WO2004084922A1 (ja) | 2003-03-26 | 2004-03-22 | 魚介類用感染防御剤 |
Country Status (2)
| Country | Link |
|---|---|
| JP (1) | JPWO2004084922A1 (ja) |
| WO (1) | WO2004084922A1 (ja) |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006265181A (ja) * | 2005-03-24 | 2006-10-05 | Univ Of Tsukuba | 魚類感染症予防製剤、魚類用餌、菌株、魚類感染症予防方法 |
| WO2008018143A1 (en) * | 2006-08-10 | 2008-02-14 | House Wellness Foods Corporation | Moisturizing agent |
| WO2023282355A1 (ja) * | 2021-07-09 | 2023-01-12 | 住友化学株式会社 | 魚類飼育用組成物、および魚病に対する予防または治療用組成物 |
| WO2023282354A1 (ja) * | 2021-07-09 | 2023-01-12 | 住友化学株式会社 | エビ目の生物の飼育用組成物、およびエビ目感染症に対する予防または治療用組成物 |
| US11571447B2 (en) | 2017-05-26 | 2023-02-07 | House Wellness Foods Corporation | Composition for preventing, ameliorating or treating metabolic syndrome |
Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62104552A (ja) * | 1985-10-31 | 1987-05-15 | Morinaga Milk Ind Co Ltd | 飼料組成物 |
| JPH04193832A (ja) * | 1990-11-27 | 1992-07-13 | Ajinomoto Co Inc | 魚類、甲殻類の細菌病予防治療剤 |
| JPH06181656A (ja) * | 1992-12-16 | 1994-07-05 | Ajinomoto Co Inc | 魚類・甲殻類のウイルス病予防治療剤及び飼料 |
| JPH10167972A (ja) * | 1996-10-11 | 1998-06-23 | Takeda Shokuhin Kogyo Kk | 免疫賦活剤 |
| JPH11228425A (ja) * | 1998-02-13 | 1999-08-24 | Takeda Food Products Ltd | Il−12産生誘導組成物 |
| JP2001064174A (ja) * | 1999-08-23 | 2001-03-13 | Takeda Food Products Ltd | 免疫賦活効果を相乗的に増強した製剤 |
| JP2001333766A (ja) * | 2000-05-24 | 2001-12-04 | Bhph Co Ltd | 新規な感染症対応型乳酸菌および該乳酸菌を主成分とした乳酸菌製剤 |
| JP2002080364A (ja) * | 2000-09-01 | 2002-03-19 | Takeda Food Products Ltd | 免疫増強組成物 |
-
2004
- 2004-03-22 WO PCT/JP2004/003884 patent/WO2004084922A1/ja not_active Ceased
- 2004-03-22 JP JP2005504045A patent/JPWO2004084922A1/ja active Pending
Patent Citations (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS62104552A (ja) * | 1985-10-31 | 1987-05-15 | Morinaga Milk Ind Co Ltd | 飼料組成物 |
| JPH04193832A (ja) * | 1990-11-27 | 1992-07-13 | Ajinomoto Co Inc | 魚類、甲殻類の細菌病予防治療剤 |
| JPH06181656A (ja) * | 1992-12-16 | 1994-07-05 | Ajinomoto Co Inc | 魚類・甲殻類のウイルス病予防治療剤及び飼料 |
| JPH10167972A (ja) * | 1996-10-11 | 1998-06-23 | Takeda Shokuhin Kogyo Kk | 免疫賦活剤 |
| JPH11228425A (ja) * | 1998-02-13 | 1999-08-24 | Takeda Food Products Ltd | Il−12産生誘導組成物 |
| JP2001064174A (ja) * | 1999-08-23 | 2001-03-13 | Takeda Food Products Ltd | 免疫賦活効果を相乗的に増強した製剤 |
| JP2001333766A (ja) * | 2000-05-24 | 2001-12-04 | Bhph Co Ltd | 新規な感染症対応型乳酸菌および該乳酸菌を主成分とした乳酸菌製剤 |
| JP2002080364A (ja) * | 2000-09-01 | 2002-03-19 | Takeda Food Products Ltd | 免疫増強組成物 |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2006265181A (ja) * | 2005-03-24 | 2006-10-05 | Univ Of Tsukuba | 魚類感染症予防製剤、魚類用餌、菌株、魚類感染症予防方法 |
| WO2008018143A1 (en) * | 2006-08-10 | 2008-02-14 | House Wellness Foods Corporation | Moisturizing agent |
| JPWO2008018143A1 (ja) * | 2006-08-10 | 2009-12-24 | ハウスウェルネスフーズ株式会社 | 保湿剤 |
| US8114658B2 (en) | 2006-08-10 | 2012-02-14 | House Wellness Foods Corporation | Method of moisturizing skin |
| JP5121715B2 (ja) * | 2006-08-10 | 2013-01-16 | ハウスウェルネスフーズ株式会社 | 保湿剤 |
| US11571447B2 (en) | 2017-05-26 | 2023-02-07 | House Wellness Foods Corporation | Composition for preventing, ameliorating or treating metabolic syndrome |
| WO2023282355A1 (ja) * | 2021-07-09 | 2023-01-12 | 住友化学株式会社 | 魚類飼育用組成物、および魚病に対する予防または治療用組成物 |
| WO2023282354A1 (ja) * | 2021-07-09 | 2023-01-12 | 住友化学株式会社 | エビ目の生物の飼育用組成物、およびエビ目感染症に対する予防または治療用組成物 |
| CN117915781A (zh) * | 2021-07-09 | 2024-04-19 | 住友化学株式会社 | 鱼类饲养用组合物和鱼病的预防或治疗用组合物 |
Also Published As
| Publication number | Publication date |
|---|---|
| JPWO2004084922A1 (ja) | 2006-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Menaga et al. | Effect of in-situ and ex-situ biofloc on immune response of Genetically Improved Farmed Tilapia | |
| Reda et al. | Effects of dietary acidifiers on growth, hematology, immune response and disease resistance of Nile tilapia, Oreochromis niloticus | |
| JP6763453B2 (ja) | 養魚用飼料 | |
| Abdel-Latif et al. | Evaluation of two phytobiotics, Spirulina platensis and Origanum vulgare extract on growth, serum antioxidant activities and resistance of Nile tilapia (Oreochromis niloticus) to pathogenic Vibrio alginolyticus | |
| Farzanfar | The use of probiotics in shrimp aquaculture | |
| Marzouk et al. | The influence of some probiotics on the growth performance and intestinal microbial flora of O. niloticus | |
| WO2017147130A2 (en) | Direct fed microbial for prevention of shrimp disease | |
| Tsekhmistrenko et al. | Efficiency of application of inorganic and nanopreparations of selenium and probiotics for growing young quails | |
| JP2015172019A (ja) | 魚介類用の免疫賦活剤 | |
| Totewad et al. | Effect of probiotic Enterococcus gallinarum N3 supplemented feed on growth performance of freshwater fish Cyprinus carpio | |
| JP4813902B2 (ja) | 抗ストレス剤 | |
| Fernandez et al. | Effect of lactic acid bacteria administered orally on growth performance of Penaeus indicus (H. Milne Edwards) juveniles | |
| Abdul-Malik et al. | Role of prebiotic, probiotic and symbiotic diets on bacterial proliferation in feed and intestine of African (Clarias gariepinus) catfish | |
| WO2004084922A1 (ja) | 魚介類用感染防御剤 | |
| Salama et al. | Effect of adding Pediococcus acidilactici at low plant protein diets on growth performance of Nile tilapia (Oreochromis niloticus) fingerlings | |
| Rhema et al. | Health and nutritional performance of young common carp Cyprinus carpio L. feeding diets with added bakery yeast Saccharomyces cerevisiae | |
| JP2022107922A (ja) | 腸内細菌叢制御用組成物 | |
| JP2010077056A (ja) | 感染症予防剤 | |
| KR102174589B1 (ko) | 뱀장어 사료내 항생제 대체를 위한 신바이오틱스 개발 | |
| JP2005330213A (ja) | 酸化ストレス抑制剤 | |
| KR100857771B1 (ko) | 바실러스 폴리퍼멘티쿠스, 바실러스 리케니포르미스 및사카로마이세스 세르비지에를 포함하는 어류사료첨가용조성물 | |
| JPH04193832A (ja) | 魚類、甲殻類の細菌病予防治療剤 | |
| Al-Noor et al. | Isolation and characterization of lactic acid bacteria from the fish intestine for application as probiotics in young common carp Cyprinus carpio L. diet | |
| Mousa et al. | Using Lactobacillus Acidophilus in Fish Feed to Improve Disease Resistance and Immune Status of Cultured Nile Tilapia. | |
| Usman et al. | A review on the role of bacillus spp. as probiotics in tilapia culture. Agrobiological Records 18: 80-95 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| AK | Designated states |
Kind code of ref document: A1 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
| AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
| WWE | Wipo information: entry into national phase |
Ref document number: 2005504045 Country of ref document: JP |
|
| 122 | Ep: pct application non-entry in european phase | ||
| DPEN | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed from 20040101) |